Abstract
From the data presented, it would appear that PiZ subjects who develop clinically significant airflow limitation go through a phase of their disease in which there is a relatively high rate of functional decline. This is encouraging in regard to the feasibility of a trial of antiprotease therapy. It suggests that beneficial effects of such therapy could be demonstrated by showing a reduction in the rate of loss of function in subjects properly selected for such a clinical trial.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S43-S45 |
| Journal | American Review of Respiratory Disease |
| Volume | 127 |
| Issue number | 2 |
| State | Published - 1983 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Fingerprint
Dive into the research topics of 'The natural history of air-flow obstruction in PiZ emphysema'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS